Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

302 Views

H4. HIV: Treatment

Poster Session: HIV: Treatment

(P-546) Eligibility and Factors Associated with Long-Acting Injectable Cabotegravir – Rilpivirine Initiation in a South Side Chicago HIV Clinic

Thursday, October 17, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Co-Author(s)

GL

Geoffroy Liegeon, MD, PhD

University of Chicago
Chicago, Illinois, United States

Presenting Author(s)

Christopher Kaperak, MD (he/him/his)

Fellow
The University of Chicago
Chicago, Illinois, United States

Co-Author(s)

EF

Eleanor Friedman, PhD

The University of Chicago
CHICAGO, Illinois, United States
PD

Paul S. Djuricich, PharmD AAHIV

Clinical Pharmacy Specialist
University of Chicago Medicine
Chicago, Illinois, United States
AD

Alicia Dawdani, BS

University of Chicago
Chicago, Illinois, United States
SP

Sophie Plotkin, MS

The University of Chicago
CHICAGO, Illinois, United States
JS

Jessica Schmitt, MSW

The University of Chicago
Chicago, Illinois, United States
AH

Aniruddha Hazra, MD

Associate Professor
University of Chicago
Chicago, Illinois, United States
KC

Katerina Christopoulos, MD, MPH (she/her/hers)

Professor of Medicine
University of California San Francisco
San Francisco, CA, United States
JS

John Schneider, MD, MPH

University of Chicago Medicine
Chicago, Illinois, United States
MM

Moira McNulty, MD

University of Chicago
Chicago, Illinois, United States